CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

The Annexure

Desk› Healthcare› Aptus Pharma Ltd

Aptus Pharma Ltd

BSE 544529 APPL INE15XJ01010
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

11 filings · 4 material · busiest 2026-08-21

What it files

Board Meeting3 Board Outcome2 Press Release1 AGM / EGM1 Annual Report1 Investor Presentation1 General1 Trading Window1

Filings

11 in the window

  1. 24 August 2026

    Press Release

    Press Release / Media Release

    Aptus Pharma Limited - Press release regarding - Aptus Pharma Limited charts next growth phase with focus on manufacturing, pan-India expansion and global markets

    Company Update / Press Release / Media Release View filing →

  2. 21 August 2026

    AGM / EGM

    NOTICE OF ANNUAL GENERAL MEETING AND E-VOTING

    Notice is hereby given that the Annual General Meeting of the Company will be held on Monday 14th September, 2026, Through Video Conferencing (VC)/ Other Audio visual means.

    AGM/EGM / AGM View filing →

  3. 21 August 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    SUB: Submission of Annual Report for the FY 2025-26 comprising of the Notice of Annual General Meeting, Directors Report, Independent Auditors Report and Audited Financial Statements

    Others / Reg. 34 (1) Annual Report View filing →

  4. 21 August 2026

    Investor Presentation

    Investor Presentation

    Intimation of investor presentation under regulation 30 of SEBI (LODR) Regulations, 2015

    Company Update / Investor Presentation View filing →

  5. 17 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Dated 17.08.2026

    Outcome of Board Meeting dated 17.08.2026

    Board Meeting / Outcome of Board Meeting View filing →

  6. 12 August 2026

    Board Meeting

    Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Monday, August 17, 2026

    Aptus Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider and approve Prior Intimation of Board Meeting ....

    Board Meeting / Board Meeting View filing →

  7. 10 August 2026

    General

    Clarification Letter In Respect Of Outcome Of Board Meeting Held On 08.08.2026

    Please find attached Clarification letter in respect of Outcome of Board meeting held on 08.08.2026 and submitted on 08.08.2026 for approval of Preferential issue of Shares

    Company Update / General View filing →

  8. 5 August 2026

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday, August 8, 2026

    Aptus Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting to ....

    Board Meeting / Board Meeting View filing →

  9. 12 June 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th June, 2026

    Outcome of Board Meeting held on 12th June, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  10. 9 June 2026

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday, June 12, 2026 And Intimation Regarding Closure Of Trading Window.

    Aptus Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2026 ,inter alia, to consider and approve Intimation of Board Meeting to ....

    Board Meeting / Board Meeting View filing →

  11. 9 June 2026

    Trading Window

    Closure of Trading Window

    Trading window shall remain closed with effect from 09th June, 2026 (5:00 P. M.), i. e. from the date of Board Meeting intimation dated 09th June, 2026 until the expiry of 48 hours after ....

    Insider Trading / SAST / Closure of Trading Window View filing →